Box 253
Container
Contains 32 Collections and/or Records:
Subcommittee on Environment, Energy, and Natural Resources, Environmental Protection Agency Closing Hearing, 1992
File — Box: 253, Folder: 1
Identifier: CAC_CC_051_9_253_1_0000
Scope and Contents
Contains witness list, memos, GAO reports, testimony, and other documents pertaining to a 1992 May 28 hearing of the Subcommittee on Environment, Energy, and Natural Resources concerning the EPA's failure to ensure timely and proper closure of hazardous waste land disposal facilities.
Subcommittee on Environment, Energy, and Natural Resources, Hazardous Waste Disposal at Tinker Air Force Base, 1992
File — Box: 253, Folder: 2
Identifier: CAC_CC_051_9_253_2_0000
Scope and Contents
Contains press statements, background materials, and meeting notes about a Superfund site at Tinker Air Force Base.
Subcommittee on Environment, Energy, and Natural Resources, Superfund Program Management Issues Hearing, 1992
File — Box: 253, Folder: 3
Identifier: CAC_CC_051_9_253_3_0000
Scope and Contents
Contains lists with handwritten notes, news releases, draft statements, memos, Synar's opening statement with highlighting, press sign in sheet, and other documents pertaining to a 1992 April 9 hearing of the Subcommittee on Environment, Energy, and Natural Resources concerning superfund management issues.
Subcommittee on Health and the Environment, Upjohn Patent Extension, 1992
File — Box: 253, Folder: 4
Identifier: CAC_CC_051_9_253_4_0000
Scope and Contents
Contains materials related to a hearing on granting the drug ANSAID additional market exclusivity.
Subcommittee on Health and the Environment, Upjohn Patent Extension, 1991
File — Box: 253, Folder: 5
Identifier: CAC_CC_051_9_253_5_0000
Scope and Contents
Contains materials related to granting the drug ANSAID additional market exclusivity.
Subcommittee on Health and the Environment, Upjohn Patent Extension, Patent Extension, undated
File — Box: 253, Folder: 6
Identifier: CAC_CC_051_9_253_6_0000
Scope and Contents
Contains materials related to various patent extensions from multiple companies. These materials were filed in a separate enclosure within a larger folder regarding the granting of additional market exclusivity to the drug ANSAID.
Subcommittee on Intellectual Property and Judicial Administration, Asbestos Hearing, 1992
File — Box: 253, Folder: 7
Identifier: CAC_CC_051_9_253_7_0000
Scope and Contents
Contains material on a hearing that took place on February 26, 1992.
Subcommittee on Intellectual Property and Judicial Administration, Asbestos Hearing, 1992
File — Box: 253, Folder: 8
Identifier: CAC_CC_051_9_253_8_0000
Scope and Contents
Contains material on a hearing that took place February 27, 1992. Material includes handwritten notes.
Subcommittee on Intellectual Property and Judicial Administration, Asbestos Hearing, Asbestos Victims Special Fund Trust, 1992
File — Box: 253, Folder: 9
Identifier: CAC_CC_051_9_253_9_0000
Scope and Contents
Contains promotional material from the Asbestos Victims Special Fund Trust. Material was in a two pocket folder that was removed left to right, front to back.
Subcommittee on Intellectual Property and Judicial Administration, Asbestos Hearing, Litigation, 1991
File — Box: 253, Folder: 10
Identifier: CAC_CC_051_9_253_10_0000
Scope and Contents
Contains material on a hearing that took place October 24, 1991.